Carregando...
Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
The safety and efficacy of the use of collagenase Clostridium histolyticum (CCH) for the treatment of Peyronie’s disease has been confirmed over the past several years. However, identification of the ideal patient population for use of this treatment is not well established. Multiple studies have at...
Na minha lista:
| Publicado no: | Patient Prefer Adherence |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338950/ https://ncbi.nlm.nih.gov/pubmed/28280315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S113507 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|